Zoetis PT Raised to $38.00 at BMO Capital Markets (ZTS)
BMO Capital Markets lifted their price objective on shares of Zoetis (NYSE:ZTS) from $36.00 to $38.00 in a research note issued on Wednesday, ARN reports. The firm currently has an “outperform” rating on the stock. BMO Capital Markets’ price objective would suggest a potential upside of 20.90% from the company’s current price.
A number of other firms have also recently commented on ZTS. Analysts at Zacks reiterated a “neutral” rating on shares of Zoetis in a research note to investors on Wednesday. They now have a $33.00 price target on the stock. Separately, analysts at Morgan Stanley upgraded shares of Zoetis from an “equal weight” rating to an “overweight” rating in a research note to investors on Friday, October 4th. They now have a $36.00 price target on the stock. Finally, analysts at Jefferies Group cut their price target on shares of Zoetis from $38.00 to $37.00 in a research note to investors on Tuesday, September 10th. They now have a “buy” rating on the stock. Five equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $36.17.
Zoetis (NYSE:ZTS) traded down 0.32% during mid-day trading on Wednesday, hitting $31.43. The stock had a trading volume of 3,379,940 shares. Zoetis has a 52-week low of $28.81 and a 52-week high of $35.42. The stock has a 50-day moving average of $30.93 and a 200-day moving average of $31.55. The company has a market cap of $15.715 billion and a price-to-earnings ratio of 37.54.
Zoetis (NYSE:ZTS) last announced its earnings results on Tuesday, August 6th. The company reported $0.36 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.36. The company had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.13 billion. The company’s quarterly revenue was up 1.8% on a year-over-year basis. Analysts expect that Zoetis will post $1.40 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Monday, December 2nd. Shareholders of record on Friday, November 1st will be paid a dividend of $0.07 per share. This represents a $0.26 annualized dividend and a dividend yield of 0.83%. The ex-dividend date is Wednesday, October 30th.
Zoetis Inc, is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.